Remove mymd-pharmaceuticals-plans-fda-cleared-phase-2-clinical-trial-of-mymd-1-in-rheumatoid-arthritis
article thumbnail

MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis

Medical Marijuana Program Connection

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® ® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and. Read More